Mereo BioPharma Group plc - ADR (MREO)
Market Open
12 Jun, 13:53
$
0. 32
+0.01
+2.6299%
$
50.76M Market Cap
- P/E Ratio
- Div Yield
512,950 Volume
0 Eps
$ 0.31
Previous Close 
Want to track MREO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mereo BioPharma Group plc - ADR (MREO) Statistics
Valuation metrics
Market Cap 50.76M
Enterprise value 13.77M
Trailing P/E (ttm) -1.41
Forward P/E -8.49
PEG ratio -0.01
Price/Sales (ttm) 99.99
Price/Book (mrq) 1.47
Enterprise Value/Revenue 27.54
Enterprise Value/EBITDA -0.35
Overview
Shares outstanding 798.08M
Float 572.33M
Shares short 6.51M
% Held by insiders 0.01%
% Held by institutions 0.48%
Average volume (10 days) 3.47M
Average volume (90 days) 1.68M
Price summary
52-Week low 0.2
52-Week high 3.05
Beta 0.38
50-Day moving average 0.28
200-Day moving average 0.72
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -71.4%
Operating margin -75.31%
Operational effectiveness
Return on assets -0.88%
Return on equity -0.81%
Income Statement
Revenue (ttm) 500K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) 367K
EBITDA -35.58M
Net income to common (ttm) -35.71M
Diluted EPS (ttm) -0.22
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 36.22M
Total cash per share (mrq) 0.23
Total debt (mrq) 202K
Total Debt/Equity (mrq) 0.49
Current ratio (mrq) 6.48%
Book value per share (mrq) 0.21
Cash Flow
Cash flow statement -33.93M
Levered free cash flow (LFCF) -41.88M
